OrthoPediatrics (KIDS) announced a new distribution partnership with MY01. This collaboration will expand access to MY01’s Continuous Perfusion Sensing Technology, CPST, Platform for children and adolescents, a population at great risk for acute compartment syndrome. “At OrthoPediatrics, we’ve always been driven by one goal: to help children whose lives have been impacted by orthopedic conditions,” said Fady Rayes, Vice-President of Product Development. “Partnering with MY01 extends that mission into trauma monitoring, pairing innovative technology with our focus on education and surgeon support.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KIDS:
- OrthoPediatrics Announces Board Member Resignation and Replacement
- OrthoPediatrics price target lowered to $35 from $50 at Citizens JMP
- OrthoPediatrics Corp Reports Strong Q2 2025 Earnings
- OrthoPediatrics price target lowered to $22 from $26 at Truist
- OrthoPediatrics price target lowered to $39 from $40 at BTIG